{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:21:55Z","timestamp":1793946115647,"version":"4.8.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFE0199200"],"award-info":[{"award-number":["2023YFE0199200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242102310093"],"award-info":[{"award-number":["242102310093"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03686-3","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:37:08Z","timestamp":1777286228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integration of blood protein-metabolic profiles via machine learning to enable the accurate early detection of non-small cell lung cancer"],"prefix":"10.1186","volume":"27","author":[{"given":"HuiYing","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaMing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuiMin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoLei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongSa","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiongRan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiFeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JunWei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShuLin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"3686_CR1","doi-asserted-by":"publisher","unstructured":"Amicizia,Daniela et al. \u201cSystematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation.\u201d Healthcare (Basel, Switzerland). 2023;11(14):2085. https:\/\/doi.org\/10.3390\/healthcare11142085.","DOI":"10.3390\/healthcare11142085"},{"issue":"11","key":"3686_CR2","first-page":"1402","volume":"45","author":"XM Nie","year":"2024","unstructured":"Nie XM, Zhang R, Huang HD. Analysis of the global and chinese lung cancer prevalence in 2022. Acad J Naval Med Univ. 2024;45(11):1402\u201307.","journal-title":"Acad J Naval Med Univ"},{"key":"3686_CR3","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. Cancer J Clin. 2024;74(1):12\u201349.","DOI":"10.3322\/caac.21820"},{"issue":"6","key":"3686_CR4","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","volume":"111","author":"CF Mountain","year":"1997","unstructured":"Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111(6):1710\u20137.","journal-title":"Chest"},{"issue":"2","key":"3686_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.lungcan.2011.11.012","volume":"76","author":"M Grunnet","year":"2012","unstructured":"Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138\u201343.","journal-title":"Lung Cancer"},{"issue":"3","key":"3686_CR6","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.18632\/oncotarget.14022","volume":"8","author":"Z Yu","year":"2017","unstructured":"Yu Z, Zhang G, Yang M, Zhang S, Zhao B, Shen G, et al. Systematic review of CYFRA 21\u2009\u2013\u20091 as a prognostic indicator and its predictive correlation with clinicopathological features in non-small cell lung cancer: A meta-analysis. Oncotarget. 2017;8(3):4043\u201350.","journal-title":"Oncotarget"},{"issue":"10","key":"3686_CR7","doi-asserted-by":"publisher","first-page":"e1391","DOI":"10.1002\/ctm2.1391","volume":"13","author":"E Dantas","year":"2023","unstructured":"Dantas E, Murthy A, Ahmed T, Ahmed M, Ramsamooj S, Hurd MA, et al. TIMP1 is an early biomarker for detection and prognosis of lung cancer. Clin Transl Med. 2023;13(10):e1391.","journal-title":"Clin Transl Med"},{"key":"3686_CR8","doi-asserted-by":"publisher","first-page":"1255527","DOI":"10.3389\/fonc.2023.1255527","volume":"13","author":"M Saviana","year":"2023","unstructured":"Saviana M, Romano G, McElroy J, Nigita G, Distefano R, Toft R, et al. A plasma miRNA-based classifier for small cell lung cancer diagnosis. Front Oncol. 2023;13:1255527.","journal-title":"Front Oncol"},{"issue":"16","key":"3686_CR9","doi-asserted-by":"publisher","first-page":"e2206518","DOI":"10.1002\/advs.202206518","volume":"10","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, O\u2019Keefe CM, Hsieh K, Cope L, Joyce SC, Pisanic TR, et al. Multiplex digital methylation-specific PCR for noninvasive screening of lung cancer. Adv Sci (Weinh). 2023;10(16):e2206518.","journal-title":"Adv Sci (Weinh)"},{"key":"3686_CR10","doi-asserted-by":"publisher","unstructured":"Smolarz M, & Widlak P. Serum Exosomes and Their miRNA Load-A Potential Biomarker of Lung Cancer. Cancers, 2021;13(6):1373. https:\/\/doi.org\/10.3390\/cancers13061373.","DOI":"10.3390\/cancers13061373"},{"issue":"8","key":"3686_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1200\/JCO.21.01460","volume":"40","author":"JF Fahrmann","year":"2022","unstructured":"Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, et al. Blood-based biomarker panel for personalized lung cancer risk assessment. J Clin Oncol. 2022;40(8):876\u201383.","journal-title":"J Clin Oncol"},{"key":"3686_CR12","doi-asserted-by":"publisher","unstructured":"Haince JF, Joubert P, Bach H, Ahmed Bux R, Tappia PS, Ramjiawan B. Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome. Int J Mol Sci. 2022;23(3):1215. Published 2022 21 Jan. https:\/\/doi.org\/10.3390\/ijms23031215.","DOI":"10.3390\/ijms23031215"},{"key":"3686_CR13","doi-asserted-by":"publisher","unstructured":"Lee KB, Ang L, Yau WP, & Seow WJ. Association between Metabolites and the Risk of Lung Cancer: a systematic literature review and meta-analysis of observational studies. Metabolites. 2020;10(9):362. https:\/\/doi.org\/10.3390\/metabo10090362.","DOI":"10.3390\/metabo10090362"},{"issue":"1","key":"3686_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-025-02521-5","volume":"25","author":"H Liu","year":"2025","unstructured":"Liu H, Xiong X, Zhu W, Wang S, Huang W, Zhu G, et al. Gut microbial metabolites in cancer immunomodulation. Mol Cancer. 2025;25(1):8.","journal-title":"Mol Cancer"},{"key":"3686_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/bs.pmbts.2024.02.007","volume":"207","author":"J Hora","year":"2024","unstructured":"Hora J, Rambhia N, Mani I. Drug repurposing for personalized medicine. Prog Mol Biol Transl Sci. 2024;207:107\u201322.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"3686_CR16","doi-asserted-by":"publisher","first-page":"100907","DOI":"10.1016\/j.tranon.2020.100907","volume":"14","author":"Y Xie","year":"2021","unstructured":"Xie Y, Meng WY, Li RZ, Wang YW, Qian X, Chan C, et al. Early lung cancer diagnostic biomarker discovery by machine learning methods. Transl Oncol. 2021;14(1):100907.","journal-title":"Transl Oncol"},{"issue":"7","key":"3686_CR17","doi-asserted-by":"publisher","first-page":"100580","DOI":"10.1016\/j.mcpro.2023.100580","volume":"22","author":"J Lazar","year":"2023","unstructured":"Lazar J, Antal-Szalmas P, Kurucz I, Ferenczi A, Jozsi M, Tornyi I, et al. Large-scale plasma proteome epitome profiling is an efficient tool for the discovery of cancer biomarkers. Mol Cell Proteom. 2023;22(7):100580.","journal-title":"Mol Cell Proteom"},{"key":"3686_CR18","doi-asserted-by":"publisher","first-page":"725284","DOI":"10.3389\/fcimb.2021.725284","volume":"11","author":"F Zhao","year":"2021","unstructured":"Zhao F, An R, Wang L, Shan J, Wang X. Specific gut microbiome and serum metabolome changes in lung cancer patients. Front Cell Infect Microbiol. 2021;11:725284.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"3686_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/0840470416642773","volume":"29","author":"S Roberts","year":"2016","unstructured":"Roberts S, Julius M. Precision medicine: Now, not when. Healthc Manage Forum. 2016;29(4):158\u201361.","journal-title":"Healthc Manage Forum"},{"issue":"1","key":"3686_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40364-023-00497-2","volume":"11","author":"R Xu","year":"2023","unstructured":"Xu R, Wang J, Zhu Q, Zou C, Wei Z, Wang H, et al. Integrated models of blood protein and metabolite enhance the diagnostic accuracy for non-small cell lung cancer. Biomark Res. 2023;11(1):71.","journal-title":"Biomark Res"},{"issue":"8","key":"3686_CR21","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1177\/0962280218784726","volume":"28","author":"M van Smeden","year":"2019","unstructured":"van Smeden M, Moons KG, de Groot JA, Collins GS, Altman DG, Eijkemans MJ, et al. Sample size for binary logistic prediction models: Beyond events per variable criteria. Stat Methods Med Res. 2019;28(8):2455\u201374.","journal-title":"Stat Methods Med Res"},{"issue":"7","key":"3686_CR22","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","volume":"38","author":"RD Riley","year":"2019","unstructured":"Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE Jr., Moons KG, et al. Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat Med. 2019;38(7):1276\u201396.","journal-title":"Stat Med"},{"issue":"12","key":"3686_CR23","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3686_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-022-03510-8","volume":"20","author":"Z Peng","year":"2022","unstructured":"Peng Z, Ye M, Ding H, Feng Z, Hu K. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer. J Transl Med. 2022;20(1):302.","journal-title":"J Transl Med"},{"issue":"3","key":"3686_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3349\/ymj.2016.57.3.549","volume":"57","author":"J Shi","year":"2016","unstructured":"Shi J, Yang H, Duan X, Li L, Sun L, Li Q, et al. Apolipoproteins as differentiating and predictive markers for assessing clinical outcomes in patients with small cell lung cancer. Yonsei Med J. 2016;57(3):549\u201356.","journal-title":"Yonsei Med J"},{"key":"3686_CR26","doi-asserted-by":"publisher","unstructured":"Madama D, Martins R, Pires AS, Botelho MF, Alves MG, Abrantes AM, & Cordeiro CR. Metabolomic Profiling in Lung Cancer: a systematic review. Metabolites, 2021;11(9):630. https:\/\/doi.org\/10.3390\/metabo11090630.","DOI":"10.3390\/metabo11090630"},{"key":"3686_CR27","doi-asserted-by":"publisher","first-page":"1039786","DOI":"10.3389\/fendo.2022.1039786","volume":"13","author":"C Pan","year":"2022","unstructured":"Pan C, Deng D, Wei T, Wu Z, Zhang B, Yuan Q, et al. Metabolomics study identified bile acids as potential biomarkers for gastric cancer: A case control study. Front Endocrinol (Lausanne). 2022;13:1039786.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3686_CR28","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1038\/s41467-025-61161-x","volume":"16","author":"M \u00d6z\u00e7am","year":"2025","unstructured":"\u00d6z\u00e7am M, Lin DL, Gupta CL, Li A, Gomez JC, Wheatley LM, et al. Gut microbial bile and amino acid metabolism associate with peanut oral immunotherapy failure. Nat Commun. 2025;16(1):6330.","journal-title":"Nat Commun"},{"key":"3686_CR29","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1080\/19490976.2020.1732268","volume":"11","author":"Y Tian","year":"2020","unstructured":"Tian Y, Gui W, Koo I, Smith PB, Allman EL, Nichols RG, et al. The microbiome modulating activity of bile acids. Gut Microbes. 2020;11:979\u201396.","journal-title":"Gut Microbes"},{"issue":"1","key":"3686_CR30","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1186\/s12864-024-11018-2","volume":"25","author":"KH Lee","year":"2024","unstructured":"Lee KH, Assassi S, Mohan C, Pedroza C. Addressing statistical challenges in the analysis of proteomics data with extremely small sample size: A simulation study. BMC Genomics. 2024;25(1):1086.","journal-title":"BMC Genomics"},{"issue":"6371","key":"3686_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137.","journal-title":"Science"},{"issue":"6","key":"3686_CR32","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-019-0447-x","volume":"25","author":"D Ardila","year":"2019","unstructured":"Ardila D, Kiraly AP, Bharadwaj S, Choi B, Reicher JJ, Peng L, et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med. 2019;25(6):954\u201361.","journal-title":"Nat Med"},{"issue":"8","key":"3686_CR33","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/sj.bjc.6605865","volume":"103","author":"EC Farlow","year":"2010","unstructured":"Farlow EC, Vercillo MS, Coon JS, Basu S, Kim AW, Faber LP, et al. A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer. 2010;103(8):1221\u20138.","journal-title":"Br J Cancer"},{"issue":"7","key":"3686_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.clinbiochem.2004.05.007","volume":"37","author":"R Molina","year":"2004","unstructured":"Molina R, Filella X, Aug\u00e9 JM, Progrp. A new biomarker for small cell lung cancer. Clin Biochem. 2004;37(7):505\u201311.","journal-title":"Clin Biochem"},{"issue":"17","key":"3686_CR35","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1158\/1078-0432.CCR-17-0577","volume":"23","author":"X Jin","year":"2017","unstructured":"Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, et al. Evaluation of tumor-derived exosomal mirna as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing. Clin Cancer Res. 2017;23(17):5311\u201319.","journal-title":"Clin Cancer Res"},{"key":"3686_CR36","doi-asserted-by":"publisher","unstructured":"Faubert B, Solmonson A, & DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science, (New York). 2020;368(6487):eaaw5473. https:\/\/doi.org\/10.1126\/science.aaw5473.","DOI":"10.1126\/science.aaw5473"},{"issue":"3","key":"3686_CR37","doi-asserted-by":"publisher","first-page":"e70375","DOI":"10.1002\/jgh3.70375","volume":"10","author":"T Hoshino","year":"2026","unstructured":"Hoshino T, Mizuide M, Suzuki Y, Yasuoka H, Naganuma A, Hatanaka T, et al. Clinical utility of the apolipoprotein A2 isoform index as a tumor marker for pancreatic cancer. JGH Open. 2026;10(3):e70375.","journal-title":"JGH Open"},{"issue":"13","key":"3686_CR38","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.7150\/ijbs.99680","volume":"20","author":"X Zhao","year":"2024","unstructured":"Zhao X, Ren T, Li S, Wang X, Hou R, Guan Z, et al. A new perspective on the therapeutic potential of tumor metastasis: Targeting the metabolic interactions between TAMs and tumor cells. Int J Biol Sci. 2024;20(13):5109\u201326.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3686_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40364-025-00859-y","volume":"13","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Bai L, Cui J. Harnessing multi-omics approaches to decipher tumor evolution and improve diagnosis and therapy in lung cancer. Biomark Res. 2025;13(1):140.","journal-title":"Biomark Res"},{"issue":"11","key":"3686_CR40","doi-asserted-by":"publisher","first-page":"e31349","DOI":"10.1002\/jcp.31349","volume":"239","author":"J Zhang","year":"2024","unstructured":"Zhang J, Chen M, Yang Y, Liu Z, Guo W, Xiang P, et al. Amino acid metabolic reprogramming in the tumor microenvironment and its implication for cancer therapy. J Cell Physiol. 2024;239(11):e31349.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3686_CR41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12964-024-01760-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, Ren B, Ren J, Gu M, You L, Zhao Y. The significant role of amino acid metabolic reprogramming in cancer. Cell Commun Signal. 2024;22(1):380.","journal-title":"Cell Commun Signal"},{"key":"3686_CR42","doi-asserted-by":"publisher","first-page":"1220638","DOI":"10.3389\/fonc.2023.1220638","volume":"13","author":"E Xu","year":"2023","unstructured":"Xu E, Ji B, Jin K, Chen Y. Branched-chain amino acids catabolism and cancer progression: Focus on therapeutic interventions. Front Oncol. 2023;13:1220638.","journal-title":"Front Oncol"},{"issue":"7","key":"3686_CR43","doi-asserted-by":"publisher","first-page":"e5880","DOI":"10.1002\/bmc.5880","volume":"38","author":"J Qian","year":"2024","unstructured":"Qian J, Zhao X, Yuan S, Su S, Chen C, Gao J, et al. Metabolome-microbiome insights into therapeutic impact of 8-O-acetylharpagide against breast cancer in a murine model. Biomed Chromatogr. 2024;38(7):e5880.","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"3686_CR44","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1053\/j.gastro.2024.12.031","volume":"168","author":"L Godny","year":"2025","unstructured":"Godny L, Elial-Fatal S, Arrouasse J, Sharar Fischler T, Reshef L, Kutukov Y, et al. Mechanistic implications of the mediterranean diet in patients with newly diagnosed crohn\u2019s disease: Multiomic results from a prospective cohort. Gastroenterology. 2025;168(5):952\u2013e642.","journal-title":"Gastroenterology"},{"issue":"7","key":"3686_CR45","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/ijc.35479","volume":"157","author":"T Zhang","year":"2025","unstructured":"Zhang T, Moore SC, Fu S, Wang X, Albanes D, Weinstein SJ, et al. Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts. Int J Cancer. 2025;157(7):1304\u201315.","journal-title":"Int J Cancer"},{"key":"3686_CR46","doi-asserted-by":"publisher","unstructured":"Nenkov M, Shi Y, Ma Y, Ga\u00dfler N, & Chen Y. Targeting Farnesoid X receptor in tumor and the tumor microenvironment: Implication for Therapy. International journal of molecular sciences. 2023;25(1):6. https:\/\/doi.org\/10.3390\/ijms25010006.","DOI":"10.3390\/ijms25010006"},{"issue":"2","key":"3686_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","volume":"37","author":"S Sivanand","year":"2020","unstructured":"Sivanand S, Vander Heiden MG. Emerging roles for branched-chain amino acid metabolism in cancer. Cancer Cell. 2020;37(2):147\u201356.","journal-title":"Cancer Cell"},{"issue":"7","key":"3686_CR48","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/ijc.29517","volume":"137","author":"E Marien","year":"2015","unstructured":"Marien E, Meister M, Muley T, Fieuws S, Bordel S, Derua R, et al. Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles. Int J Cancer. 2015;137(7):1539\u201348.","journal-title":"Int J Cancer"},{"issue":"12","key":"3686_CR49","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol. 2021;21(12):785\u201397.","journal-title":"Nat Rev Immunol"},{"key":"3686_CR50","doi-asserted-by":"publisher","unstructured":"Xu J, Zhou Y, Cheng S, Zhao Y, Yan J, Wang Y, Cai W, and Jiang L. \"Lactobacillus johnsonii attenuates liver steatosis and Bile acid dysregulation in parenteral nutrition-fed rats\" Metabolites. 2023;13(10):1043. https:\/\/doi.org\/10.3390\/metabo13101043.","DOI":"10.3390\/metabo13101043"},{"key":"3686_CR51","doi-asserted-by":"publisher","unstructured":"Ren C, Zhang S, Ma J, Huang J, Huang P, Qu M, Zhao H, Zhou Z, & Gong A. Nicotinamide Mononucleotide Alleviates Bile Acid Metabolism and Hormonal Dysregulation in Letrozole-Induced PCOS Mice. Biology, 2024;13(12):1028. https:\/\/doi.org\/10.3390\/biology13121028.","DOI":"10.3390\/biology13121028"},{"key":"3686_CR52","doi-asserted-by":"publisher","first-page":"156175","DOI":"10.1016\/j.phymed.2024.156175","volume":"135","author":"Z Chen","year":"2024","unstructured":"Chen Z, Rao X, Sun L, Qi X, Wang J, Wang S, et al. Yi-Fei-San-Jie chinese medicine formula reverses immune escape by regulating deoxycholic acid metabolism to inhibit TGR5\/STAT3\/PD-L1 axis in lung cancer. Phytomedicine. 2024;135:156175.","journal-title":"Phytomedicine"},{"issue":"1","key":"3686_CR53","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1038\/s41467-021-26685-y","volume":"12","author":"M Nie","year":"2021","unstructured":"Nie M, Yao K, Zhu X, Chen N, Xiao N, Wang Y, et al. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma. Nat Commun. 2021;12(1):6479.","journal-title":"Nat Commun"},{"key":"3686_CR54","doi-asserted-by":"publisher","unstructured":"Pierri M, Ciani G, Brunese MC, Lauro G, Terracciano S, Iorizzi M, Nardone V, Chini MG, Bifulco G, Cappabianca S, et al. Advancing non-small-cell lung cancer management through multi-omics integration: insights from genomics, metabolomics, and radiomics. Diagnostics. 2025;15(20):2586. https:\/\/doi.org\/10.3390\/diagnostics15202586.","DOI":"10.3390\/diagnostics15202586"},{"key":"3686_CR55","doi-asserted-by":"publisher","unstructured":"Narita D, Hishinuma E, Ebina-Shibuya R, Miyauchi E, Matsukawa N, Motoike IN, Kinoshita K, Koshiba S, Tsukita Y, Notsuda H, Kimura N, Saito R, Murakami K, Fujino N, Ichikawa T, Yamada M, Tamada T, & Sugiura H. Histological and genetic features and therapeutic responses of lung cancers explored via the global analysis of their metabolome profile. Lung cancer (Amsterdam, Netherlands). 2025;200:108082. https:\/\/doi.org\/10.1016\/j.lungcan.2025.108082.","DOI":"10.1016\/j.lungcan.2025.108082"},{"key":"3686_CR56","doi-asserted-by":"publisher","first-page":"1535525","DOI":"10.3389\/fonc.2025.1535525","volume":"15","author":"D Sun","year":"2025","unstructured":"Sun D, Du Y, Li R, Zhang Y. Metabolomics for early-stage lung adenocarcinoma: Diagnostic biomarker screening. Front Oncol. 2025;15:1535525.","journal-title":"Front Oncol"},{"issue":"11","key":"3686_CR57","doi-asserted-by":"publisher","first-page":"e0224365","DOI":"10.1371\/journal.pone.0224365","volume":"14","author":"A Vabalas","year":"2019","unstructured":"Vabalas A, Gowen E, Poliakoff E, Casson AJ. Machine learning algorithm validation with a limited sample size. PLoS ONE. 2019;14(11):e0224365.","journal-title":"PLoS ONE"},{"issue":"1","key":"3686_CR58","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1186\/s12889-021-11441-0","volume":"21","author":"M Parsaeian","year":"2021","unstructured":"Parsaeian M, Mahdavi M, Saadati M, Mehdipour P, Sheidaei A, Khatibzadeh S, et al. Introducing an efficient sampling method for national surveys with limited sample sizes: Application to a national study to determine quality and cost of healthcare. BMC Public Health. 2021;21(1):1414.","journal-title":"BMC Public Health"},{"key":"3686_CR59","doi-asserted-by":"crossref","unstructured":"Emwas A-H, Roy R, McKay RT, Tenori L, Saccenti E, Gowda GAN et al. NMR spectroscopy for metabolomics research. In Metabolites, 2019;9:123.","DOI":"10.3390\/metabo9070123"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03686-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03686-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03686-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:27:07Z","timestamp":1782192427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03686-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3686"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03686-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed according to the principles of the Declaration of Helsinki and approved by the Ethics Committee of Shanghai Public Health Clinical Centre (2017-Y041). All subjects provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}